Rubius Therapeutics Inc. of Cambridge is set to announce Wednesday that it has raised $120 million — one of the largest biotech financing rounds this year — to develop a novel drug-making technology.

Read the entire article here: Biotech startup Rubius raises $120m to develop red blood cell technology